Related content

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families

By Slater Emily   Langer Peter   Fendrich Volker   Habbe Nils   Chaloupka Brunhilde   Matthäi Elvira   Sina Mercedes   Hahn Stephan   Bartsch Detlef  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 335-343

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers

By Shima Kaori   Morikawa Teppei   Baba Yoshifumi   Nosho Katsuhiko   Suzuki Maiko   Yamauchi Mai   Hayashi Marika   Giovannucci Edward   Fuchs Charles   Ogino Shuji  

Cancer Causes and Control, Vol. 22, Iss. 2, 2011-02 ,pp. : 301-309

Springer Publishing Company

Access to resources Recommend Favorite

Increased C-MYC copy numbers on the background of CDKN2A loss is associated with improved survival in nodular melanoma

By Koynova Denitsa   Jordanova Ekaterina   Kukutsch Nicole   Velden Pieter   Toncheva Draga   Gruis Nelleke  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 2, 2007-02 ,pp. : 117-123

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation

By Groenendijk Floris   Taal Walter   Dubbink Hendrikus   Haarloo Cathleen   Kouwenhoven Mathilde   Bent Martin   Kros Johan   Dinjens Winand  

Journal of Neuro-Oncology, Vol. 101, Iss. 3, 2011-02 ,pp. : 405-417

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of co-overexpression of the EGFR/IGFBP-2/HIF-2A genes in astrocytomas

By Scrideli Carlos   Carlotti Carlos   Mata Juliana   Neder Luciano   Machado Helio   Oba-Sinjo Sueli   Rosemberg Sergio   Marie Suely   Tone Luiz  

Journal of Neuro-Oncology, Vol. 83, Iss. 3, 2007-07 ,pp. : 233-239

Springer Publishing Company

Access to resources Recommend Favorite